Goldman Sachs
ELV icon

Goldman Sachs’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$542M Buy
1,393,826
+119,423
+9% +$46.5M 0.07% 225
2025
Q1
$554M Sell
1,274,403
-16,827
-1% -$7.32M 0.09% 196
2024
Q4
$476M Sell
1,291,230
-704,292
-35% -$260M 0.08% 204
2024
Q3
$1.04B Buy
1,995,522
+83,705
+4% +$43.5M 0.17% 84
2024
Q2
$1.04B Buy
1,911,817
+47,949
+3% +$26M 0.18% 83
2024
Q1
$966M Sell
1,863,868
-274,047
-13% -$142M 0.17% 84
2023
Q4
$1.01B Buy
2,137,915
+97,107
+5% +$45.8M 0.19% 74
2023
Q3
$889M Buy
2,040,808
+27,400
+1% +$11.9M 0.19% 77
2023
Q2
$895M Buy
2,013,408
+170,785
+9% +$75.9M 0.19% 70
2023
Q1
$847M Sell
1,842,623
-215,911
-10% -$99.3M 0.19% 77
2022
Q4
$1.06B Sell
2,058,534
-168,336
-8% -$86.4M 0.26% 51
2022
Q3
$1.01B Buy
2,226,870
+120,066
+6% +$54.5M 0.26% 50
2022
Q2
$1.02B Buy
2,106,804
+556,209
+36% +$268M 0.25% 50
2022
Q1
$762M Buy
1,550,595
+226,437
+17% +$111M 0.16% 86
2021
Q4
$614M Buy
1,324,158
+401,016
+43% +$186M 0.12% 125
2021
Q3
$344M Sell
923,142
-337,827
-27% -$126M 0.07% 218
2021
Q2
$481M Sell
1,260,969
-427,183
-25% -$163M 0.11% 139
2021
Q1
$606M Buy
1,688,152
+330,308
+24% +$119M 0.15% 96
2020
Q4
$436M Sell
1,357,844
-143,309
-10% -$46M 0.11% 135
2020
Q3
$403M Sell
1,501,153
-253,430
-14% -$68.1M 0.11% 126
2020
Q2
$461M Sell
1,754,583
-84,060
-5% -$22.1M 0.14% 118
2020
Q1
$417M Sell
1,838,643
-632,042
-26% -$143M 0.15% 110
2019
Q4
$746M Sell
2,470,685
-69,595
-3% -$21M 0.19% 81
2019
Q3
$610M Buy
2,540,280
+263,857
+12% +$63.4M 0.18% 85
2019
Q2
$642M Buy
2,276,423
+284,621
+14% +$80.3M 0.18% 78
2019
Q1
$572M Buy
1,991,802
+448,018
+29% +$129M 0.17% 84
2018
Q4
$405M Sell
1,543,784
-248,551
-14% -$65.3M 0.13% 117
2018
Q3
$491M Sell
1,792,335
-214,873
-11% -$58.9M 0.13% 130
2018
Q2
$478M Sell
2,007,208
-817,088
-29% -$194M 0.13% 129
2018
Q1
$620M Sell
2,824,296
-560,429
-17% -$123M 0.16% 104
2017
Q4
$762M Buy
3,384,725
+905,807
+37% +$204M 0.18% 70
2017
Q3
$471M Buy
2,478,918
+257,810
+12% +$49M 0.12% 126
2017
Q2
$418M Buy
2,221,108
+7,603
+0.3% +$1.43M 0.11% 137
2017
Q1
$366M Buy
2,213,505
+28,590
+1% +$4.73M 0.1% 154
2016
Q4
$314M Buy
2,184,915
+402,963
+23% +$57.9M 0.09% 166
2016
Q3
$223M Buy
1,781,952
+103,666
+6% +$13M 0.07% 251
2016
Q2
$220M Sell
1,678,286
-108,126
-6% -$14.2M 0.07% 258
2016
Q1
$248M Buy
1,786,412
+297,059
+20% +$41.3M 0.08% 217
2015
Q4
$208M Buy
1,489,353
+106,214
+8% +$14.8M 0.07% 269
2015
Q3
$194M Buy
1,383,139
+31,836
+2% +$4.46M 0.07% 251
2015
Q2
$222M Sell
1,351,303
-269,937
-17% -$44.3M 0.07% 253
2015
Q1
$250M Sell
1,621,240
-216,262
-12% -$33.4M 0.08% 213
2014
Q4
$231M Buy
1,837,502
+200,139
+12% +$25.2M 0.07% 234
2014
Q3
$196M Buy
1,637,363
+103,699
+7% +$12.4M 0.06% 261
2014
Q2
$165M Buy
1,533,664
+288,806
+23% +$31.1M 0.05% 344
2014
Q1
$124M Sell
1,244,858
-376,851
-23% -$37.5M 0.04% 411
2013
Q4
$150M Buy
1,621,709
+864,296
+114% +$79.9M 0.05% 334
2013
Q3
$63.3M Sell
757,413
-106,818
-12% -$8.93M 0.02% 603
2013
Q2
$70.7M Buy
+864,231
New +$70.7M 0.03% 515